FDA Inspection 1017164 - Charu Aggarwal, MD, MPH, Hematology-Oncology Division - March 28, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Charu Aggarwal, MD, MPH, Hematology-Oncology Division

Record Details

This FDA Inspection record concerns Charu Aggarwal, MD, MPH, Hematology-Oncology Division, with an inspection on March 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Charu Aggarwal, MD, MPH, Hematology-Oncology Division
Inspection Date: March 28, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 47299dc4-c9e5-426e-b63d-33cf9ceec5b8

Violation Codes2

21 CFR 312.6021 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.